Milestone Pharmaceuticals Inc. SEC filings MIST
Milestone Pharmaceuticals Inc. has 421 filings in SEC EDGAR's recent list, going back to Jul 30, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Oct 28, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Other events
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 15, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2026 | Mar 20, 2026 |
| 8-K |
Current report
Other events
|
Jan 26, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Other events
|
Jan 13, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 15, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 14, 2025 | Jul 11, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 11, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Other events
|
Jun 16, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Other events
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K | Current report | Mar 19, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Sep 4, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Jul 15, 2024 | Jul 14, 2024 |
| 8-K |
Current report
Other events
|
May 29, 2024 | May 29, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Other events
|
Apr 8, 2024 | Apr 8, 2024 |
| 8-K |
Current report
Other events
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 4, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Other events
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Other events
|
Dec 26, 2023 | Dec 26, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 13, 2023 | Nov 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 9, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
New debt, Unregistered share sale, Regulation FD disclosure
|
Mar 31, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 28, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Mar 27, 2023 | Mar 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 7, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 6, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 17, 2022 | Oct 17, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jul 8, 2022 | Jul 8, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 24, 2022 | Mar 24, 2022 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Feb 16, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 14, 2021 |
| 8-K |
Current report
Other events
|
Jun 2, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 17, 2021 | May 15, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 30, 2021 | Mar 29, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 26, 2020 | Oct 22, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 22, 2020 | Sep 21, 2020 |
| 8-K |
Current report
Material agreement
|
Jul 29, 2020 | Jul 29, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 23, 2020 | Jul 22, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2020 | Jun 4, 2020 |
| 8-K |
Current report
Other events
|
Mar 23, 2020 | Mar 23, 2020 |
| 8-K |
Current report
Other events
|
Dec 17, 2019 | Dec 17, 2019 |
| 8-K |
Current report
Officer or director change
|
Dec 3, 2019 | Nov 29, 2019 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 13, 2019 | Nov 11, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2019 | Oct 8, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2019 | Sep 18, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 10, 2019 | Sep 9, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2019 | Aug 13, 2019 |
| 8-K |
Current report
Results of operations
|
May 24, 2019 | May 24, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
May 15, 2019 | May 13, 2019 |
Showing 74 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Quebec, Canada
- Headquarters
- Montreal, Quebec, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1408443
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.